Search
for
Sort by
Research 661–690 of 1000+
- Anagen effluvium in extracorporeal membrane oxygenation
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Trimethoprim-Induced Aseptic Meningitis
- Difficult and rare forms of acne
- Trimethoprim-induced aseptic meningitis
- 1,314
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
- Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients
- Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Editor's Picks February 2021
- Type 2 Diabetes Mellitus and Demodex folliculorum Infestation: A Cross-Sectional Study in Peruvian Patients
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Abstracts from the 2025 WDS Forum
- Premature graying of hairs: Ayurveda perspective
- Update on hidradenitis suppurativa: connecting the tracts
- Understanding autoimmunity of vitiligo and alopecia areata
- International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Mendelian randomization studies of testosterone exposure: A systematic review
- Serum Vaspin Level in Patients with Androgenetic Alopecia
- Madarosis: A marker of many Maladies
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- Natural bioactive compounds as potential sources for alleviation and treatment of androgenetic alopecia: A research advance
- Use of topical clascoterone for the treatment of hidradenitis suppurativa
- Insights into disparities observed with COVID‐19